REFERENCES


  1. Abernathy EC, Hruban RH, Baumgartner WA, et al. The two forms of bronchiolitis obliterans in heart-lung transplant recipients. Hum. Pathol. 191; 22: 1102.
  2. Al-Dossari GA, Jessurun J, Bolman M, Kshettry VR, King MB, Murray JJ, Hertz M. Pathogenesis of obliterative bronchiolitis - possible roles of platelet-derived growth factor and basic fibroblast growth factor. Transplant Proc. 1990; 22:2154.
  3. Allen MD, Burke CM, McGregor CGA, et al. Steroid responsive bronchiolitis after human heart-lung transplantation. J. Thorac. Cardiovasc. Surg. 1986; 92:449.
  4. Anderson WR, Coulon TF, Kiesel TM, et al. Morphologic characteristics of rejection of the baboon lung allograft. Primates Med. 1972; 7:81.
  5. Bando K, Paradis IL, Keenan RJ, Yousem SA, Komatsu K, Konishi H, Guilinger RA, Masciangelo TN, Pham SM, Armitage JM, Hardesty RL, Griffith BP. Comparison of outcomes after single and bilateral lung transplantation for obstructive lung disease. J. Heart Lung Transplant 1995; 14:692-8.
  6. Barbera JA, Hayashi S, Hergele RG, et al. Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization. Am. Rev. Respir. Dis. 1992; 145:940.
  7. Barnes BA, Flax MH, Burke JF, et al. Experimental pulmonary homografts in the dog. I. Morphological studies. Transplantation 1963; 1:351.
  8. Becroft DM. Bronchiolitis obliterans, bronchiectasis, and other sequelae of adenovirus type 21 infection in young children. J. Clin. Pathol. 1971; 24:72.
  9. Berg LC, Copenhaer CM, Morrison VA, et al. B-cell lymphoproliferative disorders in solid organ transplant patients: Dection of Epstein-Barr virus by in situ hybridization. Hum. Pathol. 1992; 23:159.
  10. Boon AP, O'Brien D, Adams DH. Ten-year review of invasive asperegillosis detected at necropsy. J. Clin. Pathol. 1991; 44:452.
  11. Brookes RG, Hofflin JM, Jamieson SW, et al. Infectious complications in heart-lung recipients. Am. J. Med. 1985; 79: 412.
  12. Burke CM, Theodore J, Dawkins KD, et al. Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest 1984; 86: 824.
  13. Burke CM, Glanville AR, Theodore J, et al. Lung immunogenicity, rejection and obliterative broncholitis. Chest 1987; 92:547.
  14. Burke CM, Yousem SA, Corris PA. Heart-lung transplantation. Diseases of the Bronchioles, edited by Gary R. Epler. Raven Press, Ltd. 1994.
  15. Byers JM, Sabanayagam P, Baker RR, et al. Pathologic changes in baboon lung allografts. Ann. Surg. 1973; 178:754.
  16. Castaneda AR, Arnar O, Schmidt-Habelbaum, et al. Cardiopulmonary autotransplantation in primates. J. Cardiovasc. Surg. 1972; 37:523.
  17. Chaparro C, Chamberlain D, Maurer J, et al. Acute lung injury in lung allografts. J. Heart Lung Transpl. 1995; 14:267-273.
  18. Clelland CA, Higenbottam TW, Monk JA, et al. Brnchoalveolar lavage lymphocytes in relation to transbronchial lung biopsy in heart-lung transplants. Transplant Proc. 1990; 22:1479.
  19. Clelland C, Higenbottam TW, Otulana B, et al. Histologic prognostic indicators for the lung allografts of heart-lung transplants. J. Heart Transplant 1990; 9:177.
  20. Clelland CA, Higenbottam TW, Stewart S, et al. Bronchoalveolar lavage and transbronchial lung biopsy during acute rejection and infection in heart-lung transplant patients. Am. Rev. Respir. Dis. 1993; 147:1386.
  21. Dark J, Corris PA. The current state of lung transplantation. Thorax 1989; 44:689.
  22. DeBlic J, Peuchmauer M, Carnot F, et al. Rejection in lung transplantation - an immunohistochemical study of transbronchial biopsies. Transplantation 1992; 54:639-644.
  23. De Hoyos AL, Chamberlain D, Schvartzman R, Ramirez J, Kesten S, Winton TL, Maurer J. Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation. Chest 1993; 103:1813-18.
  24. Denning DW, Follansbee SF, Scolaro M, et al. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N. Engl. J. Med. 1991; 324: 654.
  25. Duncan AJ, Dummer JS, Paradis IL, et al. Cytomegalovirus infection and survival in lung transplant recipients. J. Heart Lung Transplant 1991; 10:638.
  26. Dummer SJ, Montero CG, Griffith BP, et al. Infections in heart-lung transplant recipients. Transplantation 1986; 41:325.
  27. Dummer JS, White LT, Ho M, et al. Morbidity of cytomegalovirus infection heart and heart-lung transplants who received cyclosporine. J. Infect. Dis. 1985; 152: 1182.
  28. Epler GR, Colby TV. The spectrum of bronchiolitis obliterans. Chest 1983; 83: 161.
  29. Fournier M, Lebargy F, Ladurie FLR, et al. Intraepithelial T-lymphocyte subsets in the airways of normal subjects and of patients with chronic bronchitis. Am. Rev. Respir. Dis. 1989; 140: 737.
  30. Frizzera G, Hanot DW, Gaijl-Peczalska KJ, et al. Polymorphic diffuse B-cell hyperplasia and lymphomas in renal transplant recipients. Cancer Res. 1981; 41:4262.
  31. Frost AE, Keller CA, Noon GP, Short HD, Cagle PT, and the Multiorgan Transplant Group. Outcome of the native lung after single lung transplant. Chest 1995; 107:981-84.
  32. Fujimara S, Rosen V, Adommian GE, et al. Cellular characteristics of rejection response to canine lung allotransplants. J. Thorac. Cardiavasc. Surg. 1973; 65:438.
  33. Glanville AR, Baldwin JC, Burke CM, et al. Obliterative bronchiolitis after heart-lung transplantation: Apparent arrest by augmented immunosuppression. Ann. Intern Med. 1987; 107: 300.
  34. Glanville AR, Tazelaar HD, Theodore J, et al. The distribution of MHC class I and class II antigens on bronchial epithelium. Am. Rev. Respir. Dis. 1989; 139: 330.
  35. Golman M, Gerad C, Abramowicz D, et al. Induction of interleukin-6 and interleukin-10 by the OKT3 monoclonal antibody: Possible relevance to postransplant lymphroliferative disorers. Clin. Transplant 1992; 6: 265.
  36. Gray J, Wreghitt TG, Pavel P, Smyth RL, Parameshwar J, Stewart S, Cary N, Large S, Wallwork J. Epstein -Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact. J. Heart Lung Transplant 1995; 14:640-6.
  37. Griffith BP, Hardesty RL, Trento A, et al. Heart-lung transplantation: Lessons learned and future hopes. Ann. Thorac. Surg. 1987; 43:6.
  38. Grinnan GLB, Graham WH, Childs JW, et al. Cardiopulmonary homotransplantation. J. Thorac. Cardiovasc. Surg. 1970; 60:609.
  39. Gryzan S, Paradis IL, Zeevi A, et al. Unexpectedly high incidence of pneumocystis carinii infection after heart-lung transplantation: Implications for lung defense and allograft survival. Am. Rev. Respir. Dis. 1988; 137:1268.
  40. Hanto DW. Polyclonal and monoclonal post-transplant lymphoproliferative disease (LPD). Clin. Transplant 1992; 6:227.
  41. Harjula AJL, Baldwin JC, Glanville AR, et al. Human leukocyte antigen compatibility in heart-lung transplantation. J. Heart Transplant 1987; 6:162.
  42. Hasegawa S, Ockner D, Ritter J, et al. Experience of Class II major histocompatibility complex antigens and lymphocyte subset immunotyping in chronic pulmonary transplant rejection. Arch. Pathol. Lab med. 1995; 119:432-439.
  43. Haverich A, Dawkins KD, Baldwin JC, et al. Long-term cardiac and pulmonary histology in primates following combined heart and lung transplantation. Transplantation. 1985; 39:356.
  44. Herridge MS, De Hoyos AL, Chaparro C, Winton TL, Kesten S, Maurer JR. Pleural complications in lung transplant recipients. J. Thorac. Cardiovasc. Surg. 1995; 110:22-6.
  45. Higenbottam TW, Penketh AR, Stewart S, et al. The diagnosis of ung rejection and opportunistic lung infection of heart-lung transplant patients using transbronchial lung biopsy. Transplantation 1988; 46: 532.
  46. Higenbottam TW, Stewart S, Penketh AR, et al. Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. Transplantation 1988; 46:532.
  47. Higenbottam TW, Stewart S. Transbronchial lung biopsy in the diagnosis of rejection of the tranplanted lung. In Wallwork JL (ed). Heart and Lung Transplantation. Philadelphia, WB Saunders, 1989.
  48. Hines DW, Hauber MH, Yaremko L, et al. Pseudomembranous tracheobronchitis caused by aspergillus. Am. Rev. Respir. Dis. 1991; 143:1408.
  49. Holland VA, Cale PT, Windsor NT, et al. Lymphocyte subset populations in bronchiolitis obliterans after heart-lung transplantation. Transplantation 1990; 50: 955.
  50. Hruban RH, Beschorner WE, Baumgartner WA, et al. Diagnosis of lung allograft rejection by bronchial intraepithelial Leu-7 positive lymphocytes. J. Thorac Cariovasc. Surg. 1988; 96: 939.
  51. Hruban RH, Beschorner WE, Baumgartner WA, et al. Depletion of bronchus-associated lymphoid tissue with lung allograft rejection. Am. J. Pathol. 1988; 132: 6.
  52. Hruban RH, Hutchins GM. The pathology of lung transplantation. In Baumgartner WA, Achuff SC, Reitz BA (eds). Heart-Lung Transplantation. Philadelphia, WB Saunders, 1990; 372.
  53. Humbert M, Deveregne O, CerrinaJ, et al. Activation of macrophages and cytotoxic cells during cytomegalovirus pneumonia complicating lung transplants. Am. Rev. Respir. Dis. 1992; 145: 1178.
  54. Hunninghake GW, Kawanami O, Ferras VJ, et al. Characteristics of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am. Rev. Respir. Dis. 1981; 123:407.
  55. Hunt JB, Stewart S, Cary N, et al. Evaluation of the International Society for Heart Transplanaton grading of pulmonary rejection in 100 consecutive biopsies. Transplant Int. 5 1992; (Suppl)249.
  56. Hutter JA, Despins P, Higenbottam T, et al. Heart-lung transplantation: Better use of resources. Am. J. Med. 1988 85:5.
  57. Hutter JA, Stewart S, Higenbottam TW, et al. The characteristic histological changes associated with rejection in heart-lung transplant recipients. Transplant Proc. 1989; 21:435.
  58. Hutter JA, Scott FP, Wreghitt T, et al. The importance of cytomegalovirus in heart-lung recipients. Chest 1989; 95: 627.
  59. Ih-Jen S, Kai-Hsin L, Shi-Jong C, et al. Epstein-Barr virus-associated peripheral T-cell lymphoma of activated CD8 phennotype. Cancer 1990; 66: 2557.
  60. Katzenstein AL, Askin FB. Surgical Pathology of Non Neoplastic Lung Disease. Philadelphia, WB Saunders, 1982; 349.
  61. Keenan RJ, Lega ME, Dummer S, et al. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 1991; 51:433.
  62. Keller CA, Cagle PT, Brown RW, Noon G, Frost AE. Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation. Chest 1995; 107:973-80.
  63. Keogh A, Kaan A, Doran T, Macdonald P, Bryant D, Spratt P. HLA mismatching and outcome in heart, heart-lung and single lung transplantation. J. Heart Lung Transplant 1995; 14:444-51.
  64. Kondo Y, Cockrell JV, Hardy JD. Histopathology of one-stage bilateral lung allograft. Ann. Surg. 1974; 180:753.
  65. Kramer MR, Denning DW, Marshall SE, et al. Ulcerative tracheobronchitis after lung transplantation. Am. Rev. Respir. Dis. 1991; 144:552.
  66. Kriett JM, Kaye MP. The Registrar of the International Society for Heart and Lung Transplantation: EighthOffical Report. J. Heart Lung Transplantation 1991; 10:491.
  67. Lower RR, Stofer RC, Hurley EJ, et al. Cmplete homograft replacement of the heart and both lungs. Surgery 1961; 50:842.
  68. Marck KW, Wildevuur CRH, Nieuwenhuis P. Lung transplantation in the rat: Histopathology of left lung isografts and allografts. Heart Transplant1985; 4:263.
  69. Maurer JR, Tullis E, Grossman RF, et al. Infections complications following isolated lung transplantation. Chest 1992; 101:1056.
  70. McCarthy PM, Starnes VA, Theodore J, et al. Improved survival after heart-lung transplantation. J. Thorac. Cardiovasc. Surg. 1990; 99: 54.
  71. Millard PR, Heryet AR. Observations favoring pneumocystis carinii pneumonia as a primary infection: A monoclonal antibody study on paraffin sections. J. Pathol. 1988; 154:365.
  72. Millet B, Higenbottam TW, Flower CRD, et al. The radiographic appearances of infection and acute rejection of the lung after heart-lung tranplantation. Am. Rev. Respir. Dis. 1989; 140:62.
  73. Milne D, Gascoyne A, Ashcroft T, et al. Organizing pneumonia following pulmonary transplantation and the development of obliterative bronchiolitis. Transplantation 1994; 57:1757-1762.
  74. Milne DS, Gascoigne AD, Wilkes J, Sviland L, Ashcroft T, Malcolm AJ, Corris PA. MHC Class II and ICAM-1 expression biopsies from lung transplant recipients. Transplantation 1994; 57:1762-1766.
  75. Myerson D, Hackman RC, Nelson JA, et al. Widespread presence of histologically occult cytomegalovirus. Hum. Pathol. 1984; 15: 430.
  76. Nalesnik MA, Locker J, Jaffe R, et al. Experience with post-transplant lymphoproliferative disorders in solid organ transplant recipients. Clin. Transplant 1992; 6: 249.
  77. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporne A-prednisone immunosuppression. Am. J. Pathol. 1988; 133:1273.
  78. Nathan SD, Ross DJ, Belman MJ, Shain S, Elashoff JD, Kass RM, Koerner SK. Bronchiolitis obliterans in single-lung transplant recipients. Chest 1995; 107:967-72.
  79. Nibbering PH, Van der Heide A, Van Furth R. Macrophages in broncho-alveolar lavage fluid are not lungs of BCG infected mice. J. Pathol. 1989; 157: 253.
  80. Niedobiteck G, Finn T, Herbst H, et al. Detection of cytomegalovirus by in-situ hybridization and histochemistry using a monoclonal antibody CCH2. 1. Comparison of methods. J. Clin. Pathol. 1988; 41:1005.
  81. Norin AJ, Emerson EE, Kamholz SL. Cyclosporin A as the initial immunosuppressive agent for canine lung transplantation: Short and long-term assessment of rejection phenomena. Transplantation 1982; 34:372.
  82. Paradis Il, Marrari M, Zeev A, et al. HLS phenotype of lung lavage cells following heart-lung transplantation. Heart Transplant 1985; 4: 422.
  83. Pennington JE. Aspergillus lung disease. Med. Clin. North Am. 1980; 64:475.
  84. Pomerance A, Madden B, Burke MM, Yacoub MH. Transbronchial biopsy in heart and lung transplantation: clinicopathologic correlations. J. Heart Lung Transplant 1995; 14:761-773.
  85. Prop J, Juijpers P, Wildevuur CRH. Lung allograft rejection in the rat. I. accelerated rejection caused by graft lymphocytes. Tranplantation. 1985; 40:25.
  86. Prop J, Kuijpers K, Peterson AH, et al. Why are lung allografts more vigorously rejected than hearts? J. Heart Transplant 1985; 4:433.
  87. Prop J, Tazelaar HD, Billingham ME. Rejection of combined heart-lung transplants in rats: Function and pathology. Am. J. Pathol. 1987; 127:97.
  88. Prop J, Wildevuur CRH, Niewenhuis P. Lung allograft rejection in the rat. II. Specific immunological properties of lung grafts. Transplantation 1985; 40:126.
  89. Prop J, Wildevuur CRH, Nieuwenhuis P. Lung allograft rejection in the rat. III. Corresponding morphological rejection phase in various rat strain combinations. Transplantation 1985; 40:132.
  90. Reinsmoen NL, Boman RM, Savil K, et al. Differentiation of Class I- and Class II-directed donor-specific alloreactivity in bronchoalvelar lavage lymphoctyes from lung transplant recipients. Transplantation 1992; 53:181.
  91. Reitz BA, Burton NA, Jamieson SW, et al. Heart and lung transplantation. Autotransplantation and allotransplantation in primates with extended survival. J. Thorac. Cardiovasc. Surg. 1980; 80:360.
  92. Rhandhawa PS, Yousem SA, Paradis IL, et al. The clinical spectrum, pathology and clonal analysis of Epstein-Barr virus associated lymphoproloferative disorders in heart-lung transplant recipents. Am. J. Clin. Pathol. 1989; 92: 177.
  93. Romaniuk A, Prop J, Peterson AH, et al. Expression of class II major histocompatibility complex antigens by bronchial epihelium in rat lung allografts. Transplantation 1987; 44: 209.
  94. Rosendale B, Yousem SA. Discrimination of Epstein-Barr virus related posttransplant lymphoproliferations from acute rejection in lung allograft recipients. Arch. Pathol. Lab Med. 1995; 119:418-423.
  95. Schafers H-J, Haydock DA, Copper JD. The prevalence and management of bronchial anastomotic complications in lung transplantation. J. Thorac. Cardiovasc. Surg. 1991: 101:1044.
  96. Scott JP, Higenbottam TW, Hutter JA, et al. Natural history of chronic rejection in heart-lung transplant recipients. J. Heart Transplant 1990; 9: 510.
  97. Scott JP, Higenbottam TW, Sharples L, et al. Risk factors of obliterative bronchiolitis in heart-lung transplant recipients. Transplantation 1991; 51: 813.
  98. Shennib H, Nguyen D, Guttmann RD, et al. Phenotypic expresssion of bronchoalveolar lavage cells in lung rejection and infection. Am. Thorac. Surg. 1991; 51: 630.
  99. Sissons JGP, Borysiewicz LK. Human cytomegalovirus infection. Thorax 1989; 44: 241.
  100. Stewart S. Pathology of lung transplantation. Semin Diagn. Pathol. 1992; 9:210.
  101. Stewart S, Cary NRB. The pathology of heart and heart-lung transplantation; An update. J. Clin. Pathol. 1991; 44:803.
  102. Stewart S, Higenbottam TW, Hutter JA, et al. Histopathology of transbronchial biopsies in heart-lung transplantation. Transplantation Proc. XX (suppl): 1988; 764.
  103. Sundaresan S, Alevy YG, Steward N, Tucker J, Trulock EP, Cooper JD, Patterson GA, Mohanakumar T. Cytokine gene transcripts for tumor necrosis factor-a, interleukin-2, and interferon-g in human pulmonary allografts. J. Heart Lung Transplant 1995; 14:512-8.
  104. Sundaresan S, Semenkovich J, Ochoa L, Richardson G, Trulock EP, Cooper JD, Patterson GA. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. Cardiovasc. Surg. 1995; 109:1075-80.
  105. Smyth RL, Scott JP, Boysiewicz LK, et al. Cytomegalovirus infection in heart-lung transplant recipients; treatment. J. Infect. Dis. 1991; 164: 1045.
  106. Smyth RL, Higenbottam TW, Scott JP, et al. Herpes simplex virus infection in heart-lung transplant recipients. Transplantation 1990; 49: 735.
  107. Swerdlow S. Post-transplant lymphoproliferative disorders: A morphologic, phenotypic and genotypic spectrum of disease. Histopathology 1992; 20:373.
  108. Travis WD, Pittaluga S, Lipschik GY, et al. Atypical pathologic manifestation of pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Am. J. Surg. Pathol. 1990; 14: 615.
  109. Tazelaar HD. Perivascular inflammation in pulmonary infections: Implications for the diagnosis of lung rejection. J. Heart Lung Tranplant 1991; 10:437.
  110. Tazelarr HD, Baird AM, Mill M, et al. Bronchocentric mycosis occurring in transplant recipients. Chest 1989; 96:92.
  111. Tazelaar HD, Prop J. Nieuwenhuis P, et al. Airway pathology in the tranpslanted rat lung. Transplantation 1988; 45:864.
  112. Tazelaar HD, Yousem SA. The pathology of combined heart-lung transplantation. An autopsy study. Hum. Pathol. 1988; 19:1403.
  113. Theodore J, Lewiston N. Lung trasnplantation comes of age. N. Engl. J. Med. 1990; 332:772.
  114. Trulock EP. Management of lung transplant rejection. Chest 1993; 103:1566-76.
  115. Trulock EP, Bolamn RM, Genton R. Pulmonary disease caused by mycobacterium chelonei in a heart-lung transplant recipient with obliterative bronchiolitis. Am. Rev. Respir. Dis. 1989; 140:802.
  116. Trulock EP, Ettinger NA, Brunt EM, Pasque MK, Kaiser LR, Cooper JD. The role of transbronchial lung biopsy in the treatment of lung transplant recipients* an analysis of 200 consecutive procedures. Chest 1992; 102:1049-54.
  117. Veal CG, Carr JR, Briggs DD. Diffuse pneumonai and acute respiratory failure due to infections mononucleosis in a middle-aged adult. Am. Rev. Respir. Dis. 1990; 141:502.
  118. Veith FJ, Hagstrom JWC, Anderson SR, et al. Alveolar manifestations of rejection: An important cause of the poor results of human lung transplantation. Ann. Surg. 1972; 175:336.
  119. Veith FJ, Koerner SK, Siegelman SS, et al. Diagnosis and reversal of rejection in experimental and clinical lung allografts. Ann Thorac. Surg. 1973; 16:172.
  120. Veith FJ, Norin AJ, Montefusco CM, et al. Cyclosporin A in experimental lung transplantation. Transplantation 1981; 32:474.
  121. Walker RC, Paya CV, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, Daly RC, McGregor CGA. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for post-transplantation lymphoprolifertive disorder in adult heart, lung, and other solid organ transplantations. J. Heart Lung Transpl. 1995; 14:214-21.
  122. Walters EH, Gardiner PV. Bronchoalveolar lavage as a research tool. Thorax 1991; 46:613.
  123. Walts AE, Marcheysky AM, Morgan M. Pulmonary cytology in lung transplant recipients. Dian. Cytopathol. 1991; 7:353.
  124. Weber WR, Askin FB, Deher LP. Lung biopsy in pneumocystis carinii pneumonia. A histological study of typical and atypical features. Am. J. Clin. Pathol. 1977; 67:11.
  125. Weiss LM, Movahed LA, Berry GJ, et al. In situ hybridization studies for viral nucleic acids in heart and lung allograft biopsies. Am. J. Clin. Pathol. 1990; 93: 675.
  126. Wendt GH, Fox JMK, Hertz MI. Paramyxovirus infection in lung transplant recipients. J. Heart Lung Transplant 1995; 14:479-85.
  127. Winter J, Clelland C, Goaw A, Prop J. Distinct phenotypes of infiltrating cells during acute and chronic lung rejection in human heart-lung transplants. Transplantation 1995; 59:63-69.
  128. Winter J, Groen M, Welling S, et al. Inadequate antibody response against respiratory viral infection in long surviving rat lung allografts. Transplantation 1995; 59:1583-1589.
  129. Wreghitt TG, Hakim M, Gray JJ, et al. Toxoplasmosis in heart and lung transplant recipients. J. Clin. Pathol. 1989; 42:194.
  130. Wyatt S, Nunn J, et al. Airways obstruction associated with graft versus host disease after bone marrow transplantation. Thorax 1984; 39: 887.
  131. Yousem SA, Berry GJ, Brunt EM, et al. A Working Formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. J. Heart Transplant 1990; 9:593.
  132. Yousem SA, Burke CM, Billingham ME. Pathologic pulmonary alterations in long-term human heart-lung transplantation. Hum. Pathol. 1985; 16:911.
  133. Yousem SA, Curley JM, Dauber JA, et al. HLA Class II antigen expression in human heart-lung allografts, Transplantation 1990; 49: 991.
  134. Yousem SA, Curley Jm, Dauber JA, et al. Efficacy of transbronchial lung biopsy in the diagnosis of bronchiolitis obliterans. Transplantation 1989; 47:893.
  135. Yousem SA, Dauber JA, Keenan R, et al. Does histologic aute rejection in lung allografts predict the development of bronchiolitis obliterans? Transplantation 1991; 52: 306.
  136. Yousem SA, Duncan SR, Griffith BP. Interstitial and airspace granulation tissue reactions in lung transplant recipients. Am. J. Surg. Pathol. 1992; 16:877.
  137. Yousem SA, Isaacs A. Pulmonary neuroendocrine cells in the airways of lung allografts. Transplantation 1994; 59:1070-3.
  138. Yousem SA, Paradis IL, Dauber JH, et al. Pulmonary arteriosclerosis in long-term human heart-lung transplant recipients. Transplantation 1989; 47:564.
  139. Yousem SA, Randhawa P, Locker J, et al. Post-transplant lymphoproliferative disorders in heart-lung transplant recipients. Hum. Pathol. 1989; 20:361.
  140. Yousem SA, Tazelaar HD. Combined heart-lung transplantation. In Sale GE (ed). The Pathology of Organ Transplantation. Boston, Butterworths, 1990, 153.
  141. Zeevi A, Fung JJ, Paradis IL, et al. Lymphocytes of bronchoalveolar lavage from heart-lung transplanation recipents. Heart Transplant 1985; 4:417.